Serum free light chain reference ranges
| Population . | N . | Kappa (mg/L) . | Lambda (mg/L) . | Ratio . |
|---|---|---|---|---|
| Original descriptiona | 282 | 3.3-19.4 | 5.7-26.3 | 0.26-1.65 |
| General populationb,7 | 41,882 | |||
| Age <70 years | 6.3-39.0 | 5.9-36.7 | 0.44-2.16 | |
| Age ≥70 years | 7.0-55.8 | 6.4-48.0 | 0.46-2.59 | |
| Renal impairment b,8 | 6,503 | |||
| GFR 45-59 | 7.8-83.6 | 7.3-65.1 | 0.46-2.62 | |
| GFR 30-44 | 8.8-103.3 | 8.2-73.2 | 0.48-3.38 | |
| GFR <30 | 11.7-265.1 | 12.6-150.9 | 0.54-3.30 |
| Population . | N . | Kappa (mg/L) . | Lambda (mg/L) . | Ratio . |
|---|---|---|---|---|
| Original descriptiona | 282 | 3.3-19.4 | 5.7-26.3 | 0.26-1.65 |
| General populationb,7 | 41,882 | |||
| Age <70 years | 6.3-39.0 | 5.9-36.7 | 0.44-2.16 | |
| Age ≥70 years | 7.0-55.8 | 6.4-48.0 | 0.46-2.59 | |
| Renal impairment b,8 | 6,503 | |||
| GFR 45-59 | 7.8-83.6 | 7.3-65.1 | 0.46-2.62 | |
| GFR 30-44 | 8.8-103.3 | 8.2-73.2 | 0.48-3.38 | |
| GFR <30 | 11.7-265.1 | 12.6-150.9 | 0.54-3.30 |